Table 1: O2 requirements, hematological parameters and acute phase reactants during hospitalizationin ICU.
|
|
Day 1 11.06.2020 Start Lopinavir/Rionavir + Hydroxychlorochine dosing |
Day 5 16.06.2020 Stop Lopinavir/Rionavir + Hydroxychlorochine Start Thymalin dosing
|
Day 7 18.06.2020
Continuation Thymalin dosing |
Day 11 22.06.2020
Stop Thymalin dosing |
|
O2 (L/min) |
3 |
5 |
5 |
3 |
|
FiO2 (%) |
50 |
80 |
60 |
40 |
|
WBC (cells × 10^9/L) |
5.6 |
3.6 |
5.3 |
4.9 |
|
Neutrophils (cells × 10^9/L) |
4.1 |
2.4 |
3.7 |
2.9 |
|
Lymphocytes (cells × 10^9/L) |
0.62 |
0.7 |
1.0 |
1.3 |
|
Eosinophils (cells × 10^9/L) |
0.16 |
0.02 |
0.11 |
0.23 |
|
Platelets (cells × 10^9/L) |
219 |
373 |
332 |
319 |
|
CRP (mg/L) |
74.6 |
271.3 |
138.7 |
61.2 |
|
Ferritin (mcg/L) |
482 |
929 |
- |
534 |
|
D-dimer (ng/mL) |
829 |
- |
- |
- |
|
Fibrinogen (g/L) |
- |
11.3 |
9.2 |
5.4 |
|
Prothrombin time (s) |
14.2 |
21.3 |
- |
15.9 |
|
Procalcitonin (ng/mL) |
0.06 |
- |
- |
- |
|
LDH (U/L) |
421 |
568 |
474 |
399 |
|
IL-6 (pg/mL) |
25.8 |
359.2 |
- |
97.1 |